FITC-Labeled NKG2D/CD314 Fc Chimera: The "Universal Sentinel Probe" for Innate Immune Surveillance

Author: Senior Product Manager of UA Views：513

FITC-Labeled NKG2D/CD314 Fc Chimera is a core tool protein used to study the key activation pathways of innate immunity.

Recent Advances
Product Information

Recent Advances

FITC-Labeled NKG2D/CD314 Fc Chimera is a core tool protein for studying key activation pathways in innate immunity. The natural killer cell group 2 member D receptor is a major activating receptor expressed on natural killer cells, CD8⁺ αβ T cells, γδ T cells, and some macrophages. Its function is to recognize a series of ligands induced by cellular stress or malignant transformation, forming the first line of defense for the immune system to monitor "altered self." This probe creates a multifunctional, standardized universal detection platform by fusing the extracellular ligand-binding domain of human NKG2D receptor with immunoglobulin Fc fragment and FITC reporter gene, enabling specific recognition, capture, and visualization of all known human NKG2D ligands. It is widely used in research on antitumor immunity, anti-infection immunity, and autoimmune diseases.

I. Overview: Molecular Design and Structural Modules

This protein is a recombinant fusion probe designed to integrate receptor functionality, detection versatility, and operational convenience, comprising three key functional components:

NKG2D Extracellular Domain Binding Module

The core of the probe is the extracellular domain of human NKG2D protein. NKG2D (CD314) belongs to the C-type lectin-like receptor family, and its extracellular domain forms a homodimer that can recognize and bind with moderate affinity to eight different human NKG2D ligands. These ligands include MICA, MICB, and ULBP1-6, which are typically induced by cells undergoing infection, DNA damage, malignant transformation, or proliferative stress.

Fc Chimera Structure

The NKG2D extracellular domain is genetically fused with the Fc fragment of human immunoglobulin G. This design achieves dual functionality:

Universal Signal Output and Amplification: The Fc fragment provides a universal binding site for any secondary anti-Fc antibody labeled with fluorescence, enzymes, or biotin. This allows users to flexibly "assign" detection signals to different fluorescence channels or achieve signal amplification through cascade reactions based on experimental needs.

Functional Crosslinking and Effector Function Simulation: Using anti-Fc antibodies, multivalent crosslinking of the probe can be achieved on cell surfaces, mimicking receptor clustering induced by natural NKG2D ligands or agonistic antibodies for studying downstream signal activation. It can also be used to evaluate antibody-dependent cell-mediated cytotoxicity (ADCC).

FITC Fluorescent Label

Fluorescein isothiocyanate (FITC) is covalently linked to the fusion protein. FITC emits green fluorescence when excited by 488 nm laser light, serving as the most classic and versatile reporter group in flow cytometry and fluorescence microscopy, with the following advantages:

Broad Platform Compatibility: Almost all flow cytometers and fluorescence microscopes are equipped with standard FITC detection channels, ensuring experimental universality and reproducibility.

Simple and Fast Operation: As a directly labeled probe, it enables one-step staining, simplifying the process, reducing nonspecific binding, and is particularly suitable for surface labeling after intracellular staining or rapid screening.

Design Logic

This probe can be likened to a "standardized immune surveillance satellite." The NKG2D extracellular domain is a "broad-spectrum sensor" capable of scanning and locking onto various "danger signals" (NKG2D ligands); FITC is the "transmitter" that relays surveillance information in real-time via a universal "green flash signal"; and the Fc chimera serves as the "standardized data interface and control link" that allows ground stations (researchers) to switch between different receiving devices (secondary antibodies) or issue commands (crosslinking) as needed.

II. Core Mechanism: Detection Principle as a Broad-Spectrum Ligand Capture Tool

The core application mechanism of this probe is its ability to function as a soluble NKG2D receptor, capturing and labeling cells or proteins expressing the corresponding ligands.

1. Broad-Spectrum Recognition and Specific Binding

Capturing All Known Human NKG2D Ligands: Unlike antibodies targeting a single ligand, this probe can simultaneously bind MICA, MICB, and all ULBP family members, making it the most comprehensive tool for detecting total NKG2D ligand load on cell surfaces. This is crucial for assessing the overall "immunogenicity" or "danger state" of target cells.

Calcium-Dependent Specific Binding: NKG2D belongs to the C-type lectin family, and its binding is calcium-dependent, ensuring high specificity.

2. Flexible Multimodal Signal Detection

Direct Flow Cytometry: By co-incubating the probe directly with cells and detecting FITC fluorescence, the percentage of NKG2D ligand-positive cells and the mean fluorescence intensity of ligand expression can be rapidly quantified.

Indirect Signal Amplification and Multicolor Multiplexing: When higher sensitivity or channel conflict resolution is needed, the probe can be used for initial binding, followed by detection with secondary anti-Fc antibodies conjugated to other fluorophores (e.g., PE, APC), enabling signal amplification or channel shifting.

ELISA and Western Blot: Leveraging its Fc fragment, the probe can be captured on plates via anti-Fc antibodies for detecting soluble NKG2D ligands in serum, cell culture supernatants, or lysates.

3. Functional Studies and Interaction Analysis

Blocking the NKG2D Pathway: As a high-concentration soluble receptor, it can effectively competitively block the interaction between NKG2D on NK cells or CD8⁺ T cells and their ligands, thereby validating the necessity of this pathway in cytotoxicity and cytokine production in functional experiments.

Studying the Immunosuppressive Function of Soluble Ligands: Tumors or viruses may release soluble NKG2D ligands to evade immune surveillance. This probe can be used to quantify and functionally study these soluble ligands.

III. Downstream Applications: Linking Immune Surveillance to Disease Pathology

This probe is a core tool for studying the connection between immune recognition and disease, with applications spanning multiple critical fields.

1. Tumor Immunology and Cancer Research

Assessing Tumor Cell Immunogenicity: Detecting NKG2D ligand expression levels on different tumor cell lines, patient-derived primary tumor cells, or tumor organoids. High expression typically indicates greater susceptibility to NK cell- and CD8⁺ T cell-mediated killing.

Studying Tumor Immune Escape Mechanisms: Analyzing how tumor cells in the tumor microenvironment downregulate membrane expression and systemically suppress antitumor immunity by proteolytic shedding (e.g., ADAM protease cleavage of MICA/B) or exosomal secretion of soluble ligands.

Predicting Immunotherapy Efficacy: NKG2D ligand expression levels in tumor tissue may serve as biomarkers for predicting the efficacy of NK cell adoptive therapy, certain immune checkpoint inhibitors, or targeted drugs.

2. Infection and Host Defense

Identifying Virus-Infected Cells: Infections by cytomegalovirus, Epstein-Barr virus, hepatitis C virus, and others can induce or upregulate host cell expression of NKG2D ligands (e.g., ULBP). This probe can be used to identify and quantify infected cells and study viral immune evasion strategies.

Assessing Bacterial and Parasitic Infections: Certain bacterial and parasitic infections can also induce NKG2D ligand expression, and the probe can be used to study related innate immune mechanisms.

3. Autoimmune and Inflammatory Diseases

Exploring Tissue Damage and Autoimmunity: In diseases like rheumatoid arthritis and inflammatory bowel disease, damaged or stressed tissue cells may aberrantly express NKG2D ligands, which are recognized by immune cells, exacerbating inflammation. The probe can detect the expression of such "danger signals" in affected tissues.

Monitoring Transplant Rejection: Ischemia-reperfusion injury or rejection in transplanted organs can induce endothelial and parenchymal cells to express NKG2D ligands. This probe helps assess tissue damage and immune risk.

4. Immune Cell Function and Development Research

Studying NK Cell and T Cell "Licensing" and Activation: Using the probe to detect ligand levels on potential target cells for studying the activation thresholds of NK cells and γδ T cells in different functional states.

IV. Future Prospects: Toward Dynamic, Spatial, and Theranostic Integration

With technological advancements, the application scenarios of this foundational tool continue to expand and deepen.

Dynamic Live-Cell Imaging and Interaction Visualization

Using the FITC probe for time-lapse live-cell imaging to observe in real-time the aggregation, internalization, or shedding of NKG2D ligands on target cell membranes during contact with NK cells or T cells, providing intuitive insights into immune synapse dynamics.

Spatial Multi-Omics and Deep Profiling of the Tumor Microenvironment

Integrating into multiplex immunofluorescence techniques to simultaneously detect NKG2D ligand expression, immune cell infiltration, immune checkpoint molecules, and stromal features in tumor tissues, constructing high-dimensional spatial maps to reveal the mechanisms of inhibitory microenvironment formation.

Single-Cell-Level Functional-Phenotypic Correlation Analysis

Combining mass cytometry or ultra-high-dimensional flow cytometry to correlate NKG2D ligand expression profiles of target cells with activation, exhaustion, and functional molecular profiles of effector immune cells at the single-cell level, precisely analyzing pairwise cell-cell interactions.

Development and Evaluation of Novel Immunotherapy Strategies

Evaluation of Bispecific NK Cell Engagers: Serving as a standardized target-binding module to validate and optimize the binding efficiency and functionality of bispecific molecules targeting both NKG2D (simulated by this probe) and tumor antigens.

Mechanistic Studies of Combination Therapies: Investigating how radiotherapy, chemotherapy, or targeted therapy upregulate NKG2D ligand expression on tumor cells via DNA damage response ("immunogenic cell death"), thereby synergizing with immunotherapies.

Liquid Biopsy and Noninvasive Monitoring

Developing high-sensitivity detection methods based on this probe to quantitatively monitor dynamic changes in soluble NKG2D ligands in cancer patient serum, serving as noninvasive biomarkers for assessing tumor burden, treatment response, and prognosis.

Summary

FITC-Labeled NKG2D Fc Chimera is a fundamental yet powerful "universal sentinel probe" in innate immunity research. It ingeniously transforms a key "danger signal" reader (NKG2D) in the immune system into a standardized, multifunctional detection tool. With this tool, researchers can comprehensively assess the "danger level" of cells from healthy to stressed, infected, or malignant, thereby uncovering core mechanisms of immune surveillance and immune evasion in tumor immunology, infection immunology, autoimmune diseases, and other cutting-edge fields. From evaluating potential targets for cancer immunotherapy to decoding the battle between viruses and hosts, and exploring the triggers of autoinflammation, this "green sentinel" remains a reliable bridge connecting molecular recognition with immune function. In the future, combined with emerging technologies like dynamic imaging, spatial omics, and liquid biopsy, this classic probe will continue to evolve, providing indispensable insights for developing more precise immune diagnostic methods and more effective immunotherapy strategies.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next